Jonathan S. Berek Research Symposium in Gynecologic Oncology at Stanford

Registration is free for all attendees.

Register HERE

1. Summarize recent advances in the genomic and molecular profiling of ovarian and other gynecologic cancers.
2. Evaluate the role and clinical application of immunotherapy, including CAR-T cell therapy, in gynecologic oncology.
3. Apply principles of precision medicine and genetic testing to the management of women’s cancers.
4. Discuss the relevance of organoid and computational models in cancer research and therapeutic development.
5. Identify clinical trial opportunities and strategies for addressing treatment resistance in gynecologic cancers.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Live Activity for a maximum of 4.75 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this live activity for a maximum of 4.75 ANCC contact hours.

California Board of Registered Nursing (CA BRN)
Stanford Medicine Provider approved by the California Board of Registered Nursing, Provider Number 17874, for 4.75 contact hours.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require visual, auditory, cognitive, or mobility accommodations, including dietary concerns, please contact the coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health


For activity related questions, please contact
     Name: Lily Anna Mazzocco
     Title: Division Administrator & Fellowship Coordinator
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

Disclosure of faculty and their commercial relationships will be made prior to the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Oliver Dorigo, MD, PhD
Associate Professor, Director Division Gynecologic Oncology
SHC - Cancer Center

Course Director, Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lily|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Corcept|Membership on Advisory Committees or Review Panels, Board Membership, etc.-IMV (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-TORL Biotherapeutics (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-A2 Biotherapeutics (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Pheast (Relationship has ended)

Robert Bast, MD

Faculty

Royalties or Patent Beneficiary-Fujirebio

Melissa Bondy, PhD, MS

Faculty

Nothing to disclose

Elena Ioana Braicu, MD, PhD
Prof. Dr.
Charite Medical University, Berlin

Faculty

Honoraria-AstraZeneca (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AstraZeneca (Relationship has ended)|Honoraria-GlaxoSmithKline (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-GlaxoSmithKline|Grant or research support-AstraZeneca|Grant or research support-GlaxoSmithKline|Grant or research support-Roche|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Myriad (Relationship has ended)|Honoraria-Lilly (Relationship has ended)|Honoraria-AbbVie (Relationship has ended)|Honoraria-PharmaEnd (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lilly|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Gilead|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Regeneron (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-AbbVie (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-PharmaEnd (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Myriad (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Tubulis (Relationship has ended)|Grant or research support-Genmab|Grant or research support-Lilly|Grant or research support-MSD|Grant or research support-BioNTech

Katherine Ferrara, PhD
Professor
Stanford

Faculty

Nothing to disclose

Matteo Mole, PhD

Faculty

Consulting Fee-Genie Fertility|Other: Intellectual Property / Patents:-UK Patent No. BAB-C-P3371GBp|Consulting Fee-Opal Therapeutics

Erinn Rankin, PhD
Associate Professor of Radiation Oncology and of Obstetrics and Gynecology- Oncology
Stanford University

Faculty

Nothing to disclose

Parul Somani, MBA
Keynote Speaker & Decision Strategist

Faculty

Other: speaker fees-Cedar (Relationship has ended)|Other: speaker fees-Bristol Myers Squibb (Relationship has ended)

Jonathan Samuel Berek, MD
Laurie Kraus Lacob Professor
Stanford University

Planner

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck and Company, Inc. (Relationship has ended)|Grant or research support-Eisai, Inc. (Relationship has ended)|Grant or research support-Karyopharm (Relationship has ended)|Grant or research support-ImmunoGen (Relationship has ended)|Grant or research support-Tesarao (Relationship has ended)

Thursday, September 10, 2026

To view the Sponsor Prospectus, please click here.

INTERESTED IN SUPPORTING THE EVENT? PLEASE CLICK HERE TO FILL OUT THE INTEREST FORM

Note, please do not register as a supporter until you have confirmed with the CME Funding department

We recognize the value of strategic partnerships in advancing medical education and improving patient outcomes and thank you for your time and consideration. By becoming a sponsor or exhibitor, you will help support Stanford Medicine's mission to address critical healthcare needs while making a meaningful impact on the success of our learning experiences.

TERMS & CONDITIONS

Company products must be relevant to the program content. Stanford CME reserves the right to deny any application that does not meet this requirement.

Exhibitors/Sponsors and Stanford CME agree to abide by the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Stanford Medicine Industry Interactions Policy and Stanford CME Promotional Support Policy. Any actions that are not in accordance with the above stated policies may result in the removal of the exhibit/sponsor company and its representatives from the conference site, in which case no refund of exhibit/sponsor fees will be allowed.

CANCELLATION POLICY: Please contact Stanford CME Funding for cancellation details. 

The sponsor acknowledges that conducting marketing or promotional activities in any conference area except for their assigned space is prohibited. Commercial interests may not engage in sales, promotional activities, or distribute product-specific advertisements while in the designated location of the CE activity. CE activity space includes, but is not limited to, virtual lecture halls & virtual break out rooms.